Related Experiment Video
Updated: Jan 29, 2026

Single Liposome Measurements for the Study of Proton-Pumping Membrane Enzymes Using Electrochemistry and Fluorescent Microscopy
Published on: February 21, 2019
Proton Pump Inhibitor-Associated Hypomagnesemia: A Retrospective Case-Control Study
1is an acute medicine clinical pharmacy specialist at the Captain James A. Lovell Federal Health Care Center in North Chicago, Illinois. is a clinical pharmacy specialist at the Cheyenne VA Medical Center in Wyoming.
This study found a link between prescription proton pump inhibitors (PPIs) and low magnesium levels (hypomagnesemia) in veterans. Further research may be needed to confirm this association and its clinical significance.
Area of Science:
- Pharmacology
- Internal Medicine
- Clinical Research
Background:
- Proton pump inhibitors (PPIs) are widely prescribed for acid-related gastrointestinal disorders.
- Hypomagnesemia, a condition of low serum magnesium, can have serious health implications.
- The potential association between PPI use and hypomagnesemia requires further investigation.
Purpose of the Study:
- To investigate the association between prescription proton pump inhibitor use and the incidence of hypomagnesemia.
- To examine this relationship within a specific population of veterans.
Main Methods:
- Retrospective cohort study design.
- Analysis of prescription data for proton pump inhibitors.
- Monitoring of serum magnesium levels in the veteran population.
Main Results:
- A statistically significant association was observed between the use of prescription proton pump inhibitors and hypomagnesemia.
- The findings indicate a potential risk factor for hypomagnesemia in veteran PPI users.
Conclusions:
- Prescription proton pump inhibitor use is associated with an increased risk of hypomagnesemia in veterans.
- Clinicians should consider monitoring magnesium levels in patients, particularly veterans, using long-term PPI therapy.
Related Concept Videos
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
ATP Driven Pumps III: V-type Pumps
The peripheral or cytosolic V1 domain with eight subunits is involved in ATP hydrolysis. The integral or transmembrane V0 domain containing at least five subunits...
ATP Driven Pumps II: P-type Pumps
A typical P-type pump has three cytosolic domains: nucleotide-binding (N), phosphorylation (P), and activator (A) domains. These domains are connected to the membrane-spanning helices by short amino acid segments. ATP hydrolysis and covalent phosphoenzyme intermediate formation are crucial parts of the catalytic cycle. At the highly...
Pumped Concrete
For direct-acting pumps, the concrete enters the pump via the inlet valve under the action of gravity and suction created by the movement of the piston. This concrete is then forced into the pipeline and out through the outlet valve by the forward movement...

